These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3244727)

  • 1. Interactions of the novel inhibitors of MAO-B Ro 19-6327 and Ro 16-6491 with the active site of the enzyme.
    Cesura AM; Imhof R; Galva MD; Kettler R; Da Prada M
    Pharmacol Res Commun; 1988 Dec; 20 Suppl 4():51-61. PubMed ID: 3244727
    [No Abstract]   [Full Text] [Related]  

  • 2. [3H]Ro 19-6327: a reversible ligand and affinity labelling probe for monoamine oxidase-B.
    Cesura AM; Galva MD; Imhof R; Kyburz E; Picotti GB; Da Prada M
    Eur J Pharmacol; 1989 Mar; 162(3):457-65. PubMed ID: 2744079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoamine oxidase inhibition by moclobemide and 2-amino-ethyl carboxamide derivatives: mode of action and kinetic characteristics.
    Cesura AM; Muggli-Maniglio D; Lang G; Imhof R; Da Prada M
    J Neural Transm Suppl; 1990; 32():165-70. PubMed ID: 2089085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation on the structure of the active site of monoamine oxidase-B by affinity labeling with the selective inhibitor lazabemide and by site-directed mutagenesis.
    Cesura AM; Gottowik J; Lahm HW; Lang G; Imhof R; Malherbe P; Röthlisberger U; Da Prada M
    Eur J Biochem; 1996 Mar; 236(3):996-1002. PubMed ID: 8665924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MAO-B inhibition in rabbit tissues and in human platelets by Ro 19-6327 shows similar time-course.
    Kettler R; Cesura AM; Dingemanse J; Da Prada M
    J Neural Transm Suppl; 1990; 32():211-4. PubMed ID: 2089093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the binding of [3H]Ro 41-1049 to the active site of human monoamine oxidase-A.
    Cesura AM; Bös M; Galva MD; Imhof R; Da Prada M
    Mol Pharmacol; 1990 Mar; 37(3):358-66. PubMed ID: 2314388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [3H]Ro 16-6491, a selective probe for affinity labelling of monoamine oxidase type B in human brain and platelet membranes.
    Cesura AM; Imhof R; Takacs B; Galva MD; Picotti GB; Da Prada M
    J Neurochem; 1988 Apr; 50(4):1037-43. PubMed ID: 3126263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From moclobemide to Ro 19-6327 and Ro 41-1049: the development of a new class of reversible, selective MAO-A and MAO-B inhibitors.
    Da Prada M; Kettler R; Keller HH; Cesura AM; Richards JG; Saura Marti J; Muggli-Maniglio D; Wyss PC; Kyburz E; Imhof R
    J Neural Transm Suppl; 1990; 29():279-92. PubMed ID: 2193111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imidazoline-binding domains on monoamine oxidase B and subpopulations of enzyme.
    Raddatz R; Savic SL; Bakthavachalam V; Lesnick J; Jasper JR; McGrath CR; Parini A; Lanier SM
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1135-45. PubMed ID: 10688633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of [3H]Ro 16-6491, a reversible inhibitor of monoamine oxidase type B, to human brain mitochondria and platelet membranes.
    Cesura AM; Galva MD; Imhof R; Da Prada M
    J Neurochem; 1987 Jan; 48(1):170-6. PubMed ID: 3794699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
    Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
    Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of type A and B monoamine oxidase selective inhibition by Ro 41-1049 and Ro 19-6327 on dopamine outflow in rat kidney slices.
    Pestana M; Soares-da-Silva P
    Br J Pharmacol; 1994 Dec; 113(4):1269-74. PubMed ID: 7889283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lazabemide (Ro 19-6327), a reversible and highly sensitive MAO-B inhibitor: preclinical and clinical findings.
    Henriot S; Kuhn C; Kettler R; Da Prada M
    J Neural Transm Suppl; 1994; 41():321-5. PubMed ID: 7931245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro effects on monoamine uptake and release by the reversible monoamine oxidase-B inhibitors lazabemide and N-(2-aminoethyl)-p-chlorobenzamide: a comparison with L-deprenyl.
    Bondiolotti GP; Galva MD; Villa F; Sciaba L; Picotti GB
    Biochem Pharmacol; 1995 Jun; 50(1):97-102. PubMed ID: 7605351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of aging on lazabemide binding, monoamine oxidase activity and monoamine metabolites in human frontal cortex.
    Galva MD; Bondiolotti GP; Olasmaa M; Picotti GB
    J Neural Transm Gen Sect; 1995; 101(1-3):83-94. PubMed ID: 8695059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of human cerebral monoamine oxidase type B (MAO-B) activity with positron emission tomography (PET): a dose ranging study with the reversible inhibitor Ro 19-6327.
    Bench CJ; Price GW; Lammertsma AA; Cremer JC; Luthra SK; Turton D; Dolan RJ; Kettler R; Dingemanse J; Da Prada M
    Eur J Clin Pharmacol; 1991; 40(2):169-73. PubMed ID: 1906004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of inhibition of MAO-B by N-(2-aminoethyl)-p-chlorobenzamide (Ro 16-6491) and analogues.
    Mullan EL; Williams CH
    J Neural Transm Suppl; 1994; 41():307-11. PubMed ID: 7931243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of depression, cigarette smoking, and age on monoamine oxidase B in amygdaloid nuclei.
    Karolewicz B; Klimek V; Zhu H; Szebeni K; Nail E; Stockmeier CA; Johnson L; Ordway GA
    Brain Res; 2005 May; 1043(1-2):57-64. PubMed ID: 15862518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [3H]Rilmenidine-labelled imidazoline-receptor binding sites co-localize with [3H]2-(benzofuranyl)-2-imidazoline-labelled imidazoline-receptor binding sites and monoamine oxidase-B in rabbit, but not rat, kidney.
    King PR; Suzuki S; Hosseini AR; Iakovidis D; Nero TL; Jackman GP; Louis WJ; Gundlach AL
    J Auton Nerv Syst; 1998 Oct; 72(2-3):118-28. PubMed ID: 9851560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of monoamine oxidase A and B in the deamination of newly-formed dopamine in the rat kidney.
    Fernandes MH; Soares-da-Silva P
    J Neural Transm Suppl; 1990; 32():155-9. PubMed ID: 2089083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.